By proceeding, you agree to our Terms of Use and Privacy Policy.
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.
16-18 November 2022
THE INDUSTRY’S LEADING EVENT IN EUROPE TO ACCELERATE THERAPEUTICS TO MARKET BY EXPEDITING R&D, IMPROVING CMC EFFICIENCY, AND BUILDING NEW PARTNERSHIPS Access new data & case studies from world-renowned speakers and companies across the entire landsca
Event Ended
Hybrid
Paid
Vienna
07-10 May 2023
Join the TIDES conference from May 7-10, 2023, either in-person or digitally, at the Manchester Grand Hyatt San Diego. This conference is the industry's largest and most prestigious event for accelerating oligo and peptide therapeutics to market, wit
San Diego
14-17 August 2023
The Bioprocessing Summit 2023, now in its fifteenth year, stands as the premier global forum for industry leaders to converge and exchange groundbreaking advancements in bioprocess research and development, scale-up, quality, and analytics. This high
Boston